Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis

Journal of Crohn's and Colitis

Volumn 6, Issue 7, 2012, Pages 750-755

  Yamamoto, Takayuki ^a   Umegae, Satoru ^a   Matsumoto, Koichi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Corticosteroid; Granulocyte and monocyte adsorptive apheresis; Steroid dependency; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; PREDNISOLONE;

ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COLON RESECTION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG DOSE REDUCTION; EARLY INTERVENTION; FEMALE; GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; FEMALE; GRANULOCYTES; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKAPHERESIS; LONGITUDINAL STUDIES; MALE; MESALAMINE; MONOCYTES; PREDNISONE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; SULFASALAZINE; TREATMENT OUTCOME;

EID: 84863493000     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.12.009     Document Type: Article

References (20)

1. Meyers S., Janowitz H.D. Systemic corticosteroid therapy of ulcerative colitis. Gastroenterology 1985, 89:1189-1191.
2. Burger D., Travis S. Conventional medical management of inflammatory bowel disease. Gastroenterology 2011, 140:1827-1837.
3. Ford A.C., Bernstein C.N., Khan K.J., Abreu M.T., Marshall J.K., Talley N.J., et al. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2011, 106:590-599.
4. Lindgren S.C., Flood L.M., Kilander A.F., Löfberg R., Persson T.B., Sjödahl R.I. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998, 10:831-835.
5. Faubion W.A., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001, 121:255-260.
6. Bianchi Porro G., Cassinotti A., Ferrara E., Maconi G., Ardizzone S. Review article: the management of steroid dependency in ulcerative colitis. Aliment Pharmacol Ther 2007, 26:779-794.
7. Shimoyama T., Sawada K., Hiwatashi N., Sawada T., Matsueda K., Munakata A., et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001, 16:1-9.
8. Saniabadi A.R., Hanai H. Therapeutic apheresis from the early civilizations to the twenty-first century. Gastroenterol Clin Biol 2010, 34:645-648.
9. Hanai H., Watanabe F., Takeuchi K., Iida T., Yamada M., Iwaoka Y., et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003, 1:28-35.
10. Naganuma M., Funakoshi S., Sakuraba A., Takagi H., Inoue N., Ogata H., et al. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 2004, 10:251-257.
11. Domènech E., Hinojosa J., Esteve-Comas M., Gomollón F., Herrera J.M., Bastida G., et al. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther 2004, 20:1347-1352.
12. Yamamoto T., Umegae S., Kitagawa T., Yasuda Y., Yamada Y., Takahashi D., et al. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Aliment Pharmacol Ther 2004, 20:783-792.
13. Sakuraba A., Motoya S., Watanabe K., Nishishita M., Kanke K., Matsui T., et al. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 2009, 104:2990-2995.
14. Suzuki Y., Yoshimura N., Fukuda K., Shirai K., Saito Y., Saniabadi A.R. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci 2006, 51:2031-2038.
15. Tanaka T., Okanobu H., Yoshimi S., Murakami E., Kogame A., Imagawa H., et al. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients. Dig Liver Dis 2008, 40:731-736.
16. Yamamoto T., Saniabadi A.R., Maruyama Y., Umegae S., Matsumoto K. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis. Dig Liver Dis 2007, 39:626-633.
17. Tokoro C., Inamori M., Uchiyama T., Iida H., Endo H., Hosono K., et al. Efficacy of granulocytapheresis for the treatment of active ulcerative colitis and avoidance of systemic corticosteroid administration. Digestion 2010, 82:37-38.
18. Sutherland L.R., Martin F., Greer S., Robinson M., Greenberger N., Saibil F., et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987, 92:1984-1988.
19. Hanai H., Watanabe F., Yamada M., Sato Y., Takeuchi K., Iida T., et al. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion 2004, 70:36-44.
20. Yamamoto T., Umegae S., Matsumoto K. Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort study. Inflamm Bowel Dis 2010, 16:1905-1911.